| TEVAPHARMIND SP ADR (NASDAQ:TEVA) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $57.10 | 52 Week High | $59.62 | ||
| Open | $57.35 | 52 Week Low | $41.70 | ||
| Day High | $57.59 | P/E | N/A | ||
| Day Low | $56.72 | EPS | $0.00 | ||
| Volume | 1,000 | ||||
| More TEVA Info: Chart SEC Filings Profile Historical Options | |||||
Teva Pharmaceutical Industries Limited manufactures and sells generic and human pharmaceuticals, as well as active pharmaceutical ingredients in North America and internationally.
Shlomo Yanai - CEO & President
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| OGXI | 8 | MYL | 8 |
| PFE | 7 | PLX | 7 |
| WPI | 4 | CEPH | 4 |
| MRX | 4 | GSK | 3 |
| ACTI | 3 | GILD | 3 |
| BVF | 3 | SNY | 3 |
No comments are currently available.
on Jan 23, 2010
at 11:40 AM EZCHIP-EZCH, NESS TECH-NSCT, COMMTOUCH-CTCH AND VOLTAIRE-VOLT PLEASE CHECK OUT THESE EXCELLENT COMPANIES AT GREAT PRICES.
Article: RBS Initiates Coverage on Teva Pharmaceutical (TEVA) with a Buy
on Jan 8, 2010
at 07:56 PM INSIDE INFO GS ANALYST FORGET TO LET ME KNOW TOO ON IPXL ON THURSDAY MID DAY
Article: Goldman Sachs Downgraded Generics to Neutral; MYL, IPXL Cut to Neutral
on Nov 13, 2009
at 03:55 PM ANDREW OLIVER SATCHELL EXCELLENT
Article: Trading Radar for 11/03: UBS (UBS), Yamana Gold (AUY), Archer-Daniels (ADM), Royal Caribbean (RCL), Marathon (MRO) Report
on Sep 2, 2009
at 05:15 PM $10 is under esstimation !! Would like to emphsize that the holders can easily get more than $1B for FDA approved company, while $1B represent $13 of 76MM outstanding stocks. Profesionals can tell that the holder will not give up the company for much more...
Article: Hapoalim Securities Initiates Coverage on Protalix BioTherapeutics (PLX) with an Outperform; Attractive Entry Point
on Jul 24, 2009
at 09:29 AM atripla stop letting people die because a patent stops affordable drugs. healthcare is a right not a privilege as it is in Amerika.
Article: Gilead Sciences (GILD) Receives Notification of ANDA Filing for Atripla by Teva Pharma (TEVA)